Our genome sequencing lab is a part of the national r&d infrastructure network
Our genome sequencing laboratory and our Roche FLX Genome Sequencer FLX System was certified as a strategic research infrastructure by the National R&D Infrastructure Survey in this month. The Hungarian National R&D Infrastructure Survey launched as an alliance associate of the ESFRI (European Strategy Forum on Research Infrastructure) of the European Union. More»
Further news
In July, Nature Reviews Drug Discovery will publish our CEO's paper about the chances of development of novel drug compounds and targeted therapy in the future. In the 1990s, the breast cancer drug trastuzumab (Herceptin; Genentech/Roche) More»
The emergence of molecular-targeted medicine at the turn of the 21st century brought a breakthrough in the personalized treatment of tumors and inflammations, comparable only to the discovery of penicillin. At the turn of the nineteenth More»
BACKGROUND: Gastro-oesophageal reflux disease (GERD) can be associated with laryngo-respiratory symptoms (LRS) such as chronic cough, asthma or laryngeal symptoms. AIM: To analyse the long-term clinical course of LRS in a large population More»
Background: The growing use of imaging procedures in the United States has raised concerns about exposure to low-dose ionizing radiation in the general population. Methods: We identified 952,420 nonelderly adults (between 18 and 64 More»
